Synapse Medicine exports its “Yuka of medicine” with €25 million in Series B funding

Now positioned across the entire drug prescription chain and present in seven countries, Bordeaux-based startup Synapse Medicine has completed a €25 million Series B financing round with Korelya, Fleur Pellerin’s French-Korean fund. The aim is to triple in size in 24 months and accelerate the deployment of its drug information solution in the United States, in particular Good Med, which is presented as the “Yuka of medicine”.